IP20-09: Circulating tumor DNA as a biomarker for upstaging and adverse pathology in high-risk non–muscle-invasive bladder cancer

Friday, May 15, 2026 3:30 PM to 5:30 PM · 1 hr. 59 min. (America/New_York)
146A
Abstract

Log in

See all the content and easy-to-use features by logging in or registering!